Jianming Bao

8 Patents

• US125401322026

  Preparation of Tetrahydroindazole Derivatives as Novel Diacylglyceride O-acyltransferase 2 Inhibitors

  Merck Sharp & Dohme LLC

  0 cites
• US125287862026

  Plasma Kallikrein Inhibitors

  Merck Sharp & Dohme LLC

  0 cites
• US124599272025

  Plasma Kallikrein Inhibitors

  Merck Sharp & Dohme LLC

  0 cites
• US124483842025

  Diacylglyceride O-acyltransferase 2 Inhibitors

  Merck Sharp & Dohme LLC

  0 cites
• US124284112025

  Preparation of Oxindole Derivatives as Novel Diacylglyceride O-acyltransferase 2 Inhibitors

  Merck Sharp & Dohme LLC

  0 cites
• US124101592025

  Preparation of Oxindole Derivatives as Novel Diacylglyceride O-acyltransferase 2 Inhibitors

  Merck Sharp & Dohme LLC

  0 cites
• US119760612024

  Preparation of Benzimidazolone Derivatives as Novel Diacylglyceride O-acyltransferase 2 Inhibitors

  Merck Sharp & Dohme, LLC

  0 cites
• US119704792024

  3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators of the M4 Muscarinic Acetylcholine Receptor

  MSD R&D (China) Co. Ltd.

  0 cites